Nuclear Medicine: Page 127

SNMMI: Amyloid PET clarifies Alzheimer's FDG-PET scans

By Wayne Forrest

BALTIMORE - Researchers from the University of California, Los Angeles are adding to the evidence that amyloid PET imaging can be a valuable resource for diagnosing and treating Alzheimer's disease. They presented their findings on Monday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 8, 2015

Navidea touts Lymphoseek study at SNMMI

By AuntMinnie.com staff writers

Navidea Biopharmaceuticals is touting a study presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 meeting that suggests its Lymphoseek agent causes less pain than imaging with a filtered technetium-99m sulfur colloid radiotracer.

June 8, 2015

SNMMI names top leaders for 2015-2016

By AuntMinnie.com staff writers

BALTIMORE - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has appointed Dr. Hossein Jadvar, PhD, as its new president for 2015-2106.

June 7, 2015

Gamma Medica appoints new CEO, VP of sales

By AuntMinnie.com staff writers

Molecular imaging developer Gamma Medica has appointed a new CEO and vice president of sales.

June 7, 2015

GE launches cyclotron, PET tracer system at SNMMI 2015

By AuntMinnie.com staff writers

GE Healthcare has launched a new cyclotron and a new version of its PET tracer production platform at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 meeting.

June 7, 2015

SNMMI: PET prostate image lands Image of the Year honors

By Wayne Forrest

BALTIMORE - A PET radiotracer for prostate cancer that can be labeled with different radioisotopes for both diagnostic and therapeutic use won Image of the Year honors at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 7, 2015

SNMMI: PET with carbon-11 detects immune response

By AuntMinnie.com staff writers

Researchers from Yale University used a PET radiopharmaceutical based on carbon-11 to measure an immune response in the brain that could be used in future research on neuroinflammation for pathologies such as Alzheimer's disease, according to research presented this week at the Society for Nuclear Medicine and Molecular Imaging annual meeting.

June 7, 2015

SNMMI: PET beats other modalities for prostate cancer

By AuntMinnie.com staff writers

PET performed with a new imaging agent finds more prostate cancer than other modalities, including CT, MRI, and PET with conventional radiotracers, according to a study presented at this week's Society of Nuclear Medicine and Molecular Imaging meeting.

June 7, 2015

SNMMI: PET/CT with Ga-68 DOTATOC targets neuroendocrine tumors

By AuntMinnie.com staff writers

PET/CT scans with the investigational radiopharmaceutical gallium-68 (Ga-68) DOTATOC homed in on neuroendocrine tumors and changed patient management in a number of cases, according to a study presented at this week's Society of Nuclear Medicine and Molecular Imaging annual meeting.

June 7, 2015

SNMMI: New radiotracer targets ovarian, prostate cancer

By AuntMinnie.com staff writers

A protein linked to polyethylene glycol chains can attach itself to ovarian and prostate cells and could be used for imaging and personalized cancer treatment, according to a study presented this week at the 2015 Society of Nuclear Medicine and Molecular Imaging meeting.

June 7, 2015

SNMMI names Townsend as Aebersold Award recipient

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named David W. Townsend, PhD, as this year's recipient of the Paul C. Aebersold Award.

June 7, 2015

SNMMI: Amyloid scintigraphy predicts major cardiac events

By AuntMinnie.com staff writers

A new scintigraphy molecular imaging scan can pinpoint the dangerous buildup of amyloid proteins in the heart and predict major adverse cardiac events, according to a study presented this week at the Society of Nuclear Medicine and Molecular Imaging conference in Baltimore.

June 7, 2015

Previous Page

Page 127 of 438

Next Page